Cited by 342Cancer Immunotherapy and BiomarkersRadiomics and Machine Learning in Medical ImagingArtificial Intelligence in Healthcare and Education

The DOI matches its Crossref record; 145 of the 150 references it cites were found in a registry or an index.

Artificial intelligence for predictive biomarker discovery in immuno-oncology: a systematic review

Open access

Prelaj, A., Miskovic, V., Zanitti, M., Trovo, F., Genova, C., Viscardi, G., Rebuzzi, S.E., Mazzeo, L., Provenzano, L., Kosta, S., Favali, M., Spagnoletti, A., Castelo-Branco, L., Dolezal, J., Pearson, A.T., Lo Russo, G., Proto, C., Ganzinelli, M., Giani, C., Ambrosini, E., Turajlic, S., Au, L., Koopman, M., Delaloge, S., Kather, J.N., de Braud, F., Garassino, M.C., Pentheroudakis, G., Spencer, C., Pedrocchi, A.L.G.·2024·Annals of Oncology

DOI 10.1016/j.annonc.2023.10.125

Open this paper in CoChat — free account Open PDF

Abstract

Background The widespread use of immune checkpoint inhibitors (ICIs) has revolutionised treatment of multiple cancer types. However, selecting patients who may benefit from ICI remains challenging. Artificial intelligence (AI) approaches allow exploitation of high-dimension oncological data in research and development of precision immuno-oncology.Materials and methods We conducted a systematic literature review of peer-reviewed original articles studying the ICI efficacy prediction in cancer patients across five data modalities: genomics (including genomics, transcriptomics, and epigenomics), radiomics, digital pathology (pathomics), and real-world and multimodality data.Results A total of 90 studies were included in this systematic review, with 80% published in 2021-2022. Among them, 37 studies included genomic, 20 radiomic, 8 pathomic, 20 real-world, and 5 multimodal data. Standard machine learning (ML) methods were used in 72% of studies, deep learning (DL) methods in 22%, and both in 6%. The most frequently studied cancer type was non-small-cell lung cancer (36%), followed by melanoma (16%), while 25% included pan-cancer studies. No prospective study design incorporated AI-based methodologies from the outset; rather, all implemented AI as a post hoc analysis. Novel biomarkers for ICI in radiomics and pathomics were identified using AI approaches, and molecular biomarkers have expanded past genomics into transcriptomics and epigenomics. Finally, complex algorithms and new types of AI-based markers, such as meta-biomarkers, are emerging by integrating multimodal/multi-omics data.Conclusion AI-based methods have expanded the horizon for biomarker discovery, demonstrating the power of integrating multimodal data from existing datasets to discover new meta-biomarkers. While most of the included studies showed promise for AI-based prediction of benefit from immunotherapy, none provided high-level evidence for immediate practice change. A priori planned prospective trial designs are needed to cover all lifecycle steps of these software biomarkers, from development and validation to integration into clinical practice.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.annonc.2023.10.125

Cites

145 of 145 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Random Forests
Breiman, L. (2001) · Machine Learning · doi:10.1023/a:1010933404324 · Cited by 133,538
Deep learning
LeCun, Y., Bengio, Y., & Hinton, G. (2015) · Nature · doi:10.1038/nature14539 · Cited by 84,126
An Image is Worth 16x16 Words: Transformers for Image Recognition at Scale
Dosovitskiy, A., Beyer, L., Kolesnikov, A., Weissenborn, D., Zhai, X., Unterthiner, T., Dehghani, M., Minderer, M., Heigold, G., Gelly, S., et al. (2020) · arXiv · doi:10.48550/arxiv.2010.11929 · Cited by 47,472
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Cerami, E., Gao, J., Dogrusoz, U., Gross, B. E., Sumer, S. O., Aksoy, B. A., Jacobsen, A., Byrne, C. J., Heuer, M. L., Larsson, E., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0095 · Cited by 17,455
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Gao, J., Aksoy, B. A., Dogrusoz, U., Dresdner, G., Gross, B., Sumer, S. O., Sun, Y., Jacobsen, A., Sinha, R., Larsson, E., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2004088 · Cited by 15,160
Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead
Rudin, C. (2019) · Nature Machine Intelligence · doi:10.1038/s42256-019-0048-x · Cited by 10,561
Explainable Artificial Intelligence (XAI): Concepts, taxonomies, opportunities and challenges toward responsible AI
Barredo Arrieta, A., Díaz-Rodríguez, N., Del Ser, J., Bennetot, A., Tabik, S., Barbado, A., Garcia, S., Gil-Lopez, S., Molina, D., Benjamins, R., et al. (2020) · Information Fusion · doi:10.1016/j.inffus.2019.12.012 · Cited by 10,423
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer
Reck, M., Rodríguez-Abreu, D., Robinson, A. G., Hui, R., Csőszi, T., Fülöp, A., Gottfried, M., Peled, N., Tafreshi, A., Cuffe, S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1606774 · Cited by 10,089
Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer
Borghaei, H., Paz-Ares, L., Horn, L., Spigel, D. R., Steins, M., Ready, N. E., Chow, L. Q., Vokes, E. E., Felip, E., Holgado, E., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1507643 · Cited by 9,335

Show all 150 references

Sorted by citations

Items 101–200 of 342

Artificial intelligence and machine learning-driven advancements in gastrointestinal cancer: Paving the way for precision medicine
Suri, C., Ratre, Y. K., Pande, B., Bhaskar, L. V., & Verma, H. K. (2026) · World Journal of Gastroenterology · doi:10.3748/wjg.v32.i1.111428 · Cited by 10
Decision model for durable clinical benefit from front- or late-line immunotherapy alone or with chemotherapy in non-small cell lung cancer
Zhao, J., Wang, L., Zhou, A., Wen, S., Fang, W., Zhang, L., Duan, J., Bai, H., Zhong, J., Wan, R., et al. (2024) · Med · doi:10.1016/j.medj.2024.04.011 · Cited by 7
Unveiling the landscape of pathomics in personalized immunotherapy for lung cancer: a bibliometric analysis
Yuan, L., Shen, Z., Shan, Y., Zhu, J., Wang, Q., Lü, Y., & Shi, H. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1432212 · Cited by 7
A preliminary study on the diagnostic performance of the uPath PD-L1 (SP263) artificial intelligence (AI) algorithm in patients with NSCLC treated with PD-1/PD-L1 checkpoint blockade
Cortellini, A., Zampacorta, C., Tursi, M. D., Grillo, L. R., Ricciardi, S., Bria, E., Martini, M., Giusti, R., Filetti, M., Mas, A. D., et al. (2024) · Pathologica · doi:10.32074/1591-951x-998 · Cited by 7
Artificial Intelligence for Drug Discovery: An Update and Future Prospects
Howell, H. J., McGale, J., Choucair, A., Shirini, D., Aide, N., Postow, M. A., Wang, L., Tordjman, M., Lopci, E., Lecler, A., et al. (2025) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2025.01.004 · Cited by 7
Artificial Intelligence in Clinical Oncology: From Productivity Enhancement to Creative Discovery
Kuno, M., Osumi, H., Udagawa, S., Yoshikawa, K., Ooki, A., Shinozaki, E., Ishikawa, T., Oba, J., Yamaguchi, K., & Sakurada, K. (2025) · Current Oncology · doi:10.3390/curroncol32110588 · Cited by 7
Organ-specific cancer biomarker identification: a ten-year single-center study in southern China
Chang, Z., Chen, B., Wang, S., Chen, K., Huang, L., Yang, Y., Wu, H., Jian, W., Cheng, Z. J., Han, X., et al. (2025) · BMC Cancer · doi:10.1186/s12885-025-14225-6 · Cited by 6
Machine learning‑based radiomics models for the prediction of metachronous liver metastases in patients with colorectal cancer: A multimodal study
Wang, J., Zhang, Z.-N., Shu, D.-B., Huang, Y., Tang, W., Zhao, H.-B., Zhao, Z., & Sun, J. (2025) · Oncology Letters · doi:10.3892/ol.2025.15140 · Cited by 6
Artificial Intelligence in digital pathology of breast cancer, new era of practice?
Li, W., Ye, S., Jin, Z., Chen, L., Chao, Y., Wei, G., Huang, Q., Tu, H., & Wang, Q. (2025) · International Journal of Surgery · doi:10.1097/js9.0000000000002953 · Cited by 7
Systemic immune-inflammatory biomarkers combined with the CRP-albumin-lymphocyte index predict surgical site infection following posterior lumbar spinal fusion: a retrospective study using machine learning
Pang, Z., Liang, J., Chen, J., Ou, Y., Wu, Q., Huang, S., Huang, S., & Chen, Y. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1590248 · Cited by 6
Artificial intelligence in endometriosis care: A comparative analysis of large language model and human specialist responses to endometriosis-related queries
Burla, L., Metzler, J. M., Kalaitzopoulos, D. R., Kamm, S., Ormos, M., Passweg, D. E., Schraag, S. M., Samartzis, E. P., Samartzis, N., Witzel, I., et al. (2025) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2025.114625 · Cited by 6
Artificial intelligence in biomaterials for oral oncology
Miao, X.-Y., Chen, L., Zhang, S., Li, J., Feng, Y., Li, X., Wei, J., Xue, Y., Bai, S.-Z., Tay, F. R., et al. (2026) · Biomaterials · doi:10.1016/j.biomaterials.2026.124067 · Cited by 6
Applying 12 machine learning algorithms and Non-negative Matrix Factorization for robust prediction of lupus nephritis
Mou, L., Lu, Y., Wu, Z., Pu, Z., Huang, X., & Wang, M. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1391218 · Cited by 6
A potential predictive model based on machine learning and CPD parameters in elderly patients with aplastic anemia and myelodysplastic neoplasms
Qi, Y., Liu, X., Ding, Z., Yu, Y., & Zhuang, Z. (2024) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-024-02781-z · Cited by 6
Machine Learning-Driven Transcriptome Analysis of Keratoconus for Predictive Biomarker Identification
Chang, S.-H., Yeh, L., Hung, K.-H., Chiu, Y., Hsieh, C., & Ma, C. (2025) · Biomedicines · doi:10.3390/biomedicines13051032 · Cited by 6
Unlocking oral oncology: AI-powered biomarker discovery for early detection
Karishma, S., & Saravanan, A. (2024) · Oral Oncology Reports · doi:10.1016/j.oor.2024.100427 · Cited by 5
Artificial Intelligence‐Based Multimodal Prediction of Postoperative Adjuvant Immunotherapy Benefit in Urothelial Carcinoma: Results From the Phase III, Multicenter, Randomized, IMvigor010 Trial
Huang, X., Qiu, W., Kong, Y., Ou, Q., Mao, Q., Fang, Y., Fan, Z., Wu, J., Lu, X., Gu, W., et al. (2025) · MedComm · doi:10.1002/mco2.70324 · Cited by 6
Computational pathology approach for assessment of prognosis and immunotherapy response in pan-gastrointestinal cancer
Zhang, T., Sun, Z., Li, Z., Ahmad, M. U., Islam, M. T., Yang, X., Yang, X., Wu, L., Xie, J., Feng, W., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06181-3 · Cited by 5
Explainable artificial intelligence for multi-modal cancer analysis: from genomics to immunology
Zhang, M., & Yin, L. (2026) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.105040 · Cited by 5
Human biomarker navigator
Li, M., Zhang, Q., Wang, Z., Gui, Z., Liu, J., Li, J., Jiang, M., Chang, Z., Han, Q., Yang, B., et al. (2026) · iMeta · doi:10.1002/imt2.70157 · Cited by 6
Key considerations when implementing new diagnostic technologies in routine practice
Lennerz, J. K. (2024) · Die Pathologie · doi:10.1007/s00292-024-01396-5 · Cited by 5
Development and validation of MRI-derived deep learning score for non-invasive prediction of PD-L1 expression and prognostic stratification in head and neck squamous cell carcinoma
Ding, C., Kang, Y., Bai, F., Bai, G., & Xian, J. (2025) · Cancer Imaging · doi:10.1186/s40644-025-00837-5 · Cited by 5
Polymerase Chain Reaction Chips for Biomarker Discovery and Validation in Drug Development
Vo, D.-K., & Trinh, K. T. L. (2025) · Micromachines · doi:10.3390/mi16030243 · Cited by 7
Companion Tests and Personalized Cancer Therapy: Reaching a Glass Ceiling
Ferrari, V., Mograbi, B., Gal, J., & Milano, G. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25189991 · Cited by 5
How to optimize the immune checkpoint blockade therapy for cancers?
Guo, H., Hou, Y., Wang, C., & Ding, J. (2024) · ONCOLOGIE · doi:10.1515/oncologie-2024-0037 · Cited by 5
The complexities of PD-L1 expression as an indicator of immunotherapy outcomes
Needleman, R., & Thai, A. A. (2025) · Immunotherapy · doi:10.1080/1750743x.2025.2500908 · Cited by 4
Artificial Intelligence in melanoma research: a bibliometric analysis
Guo, Y., Huang, X., Chen, F., Ma, J., Lv, Y., Yang, T., Guo, Q., & Sun, Y. (2025) · International Journal of Surgery · doi:10.1097/js9.0000000000003879 · Cited by 5
Artificial Intelligence in Oncology
Jeziorski, K., & Olszewski, R. (2024) · Applied Sciences · doi:10.3390/app15010269 · Cited by 4
Development and Validation of an Ultrasound-Based Clinical Radiomics Nomogram for Diagnosing Gouty Arthritis
Lin, M., Yan, L., He, M., & Chen, S. (2025) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2024.12.009 · Cited by 4
GCBRGCN: Integration of ceRNA and RGCN to Identify Gastric Cancer Biomarkers
Zhi, P., Liu, Y., Zhao, C., & He, K. (2025) · Bioengineering · doi:10.3390/bioengineering12030255 · Cited by 4
Utilizing PET Imaging To Visualize Immune Activation and Tumor Apoptosis
Yuan, F., Lin, Z., Hu, W., Wang, X., Zhang, Z., Lan, X., & Zhang, X. (2025) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.4c01314 · Cited by 4
Interpretable multiparametric MRI radiomics-based machine learning model for preoperative differentiation between benign and malignant prostate masses: a diagnostic, multicenter study
Zhou, W., Liu, Z., Zhang, J., Su, S., Luo, Y., Jiang, L., Han, K., Huang, G., Wang, J., Lan, J.-H., et al. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1541618 · Cited by 4
Tracking the Response to Immunotherapy: Blood microRNA Dynamics in Patients With Advanced Non–Small Cell Lung Cancer
Chiaruttini, M. V., Proto, C., Russo, G. L., Prelaj, A., Segale, M., Zanghì, A., Galli, F., Greco, F. G., Signorelli, D., Brambilla, M., et al. (2025) · JCO Precision Oncology · doi:10.1200/po-24-00790 · Cited by 4
Self-citation
Development and clinical validation of deep learning-based immunohistochemistry prediction models for subtyping and staging of gastrointestinal cancers
Wang, J., Zhang, S., Li, J., Deng, M., Zeng, Z., Dong, Z., Chen, F.-F., Liu, W., Wu, L., & Yu, H. (2025) · BMC Gastroenterology · doi:10.1186/s12876-025-04045-0 · Cited by 4
Gaps between medical biology and AI drug discovery
Yin, Y., Fu, A., & Wang, L. (2025) · Drug Discovery Today · doi:10.1016/j.drudis.2025.104512 · Cited by 4
Artificial Intelligence-Based Methods and Omics for Mental Illness Diagnosis: A Review
de Oliveira, G. S., Rodrigues, F. H. D. S., Pontes, J. G. D. M., & Tasić, L. (2025) · Bioengineering · doi:10.3390/bioengineering12101039 · Cited by 4
Development and multi-center validation of machine learning models based on targeted metabolomics for rheumatoid arthritis
Tang, J., Jiang, R., Gao, H., Xia, J., Ma, Y., Han, Z., Yu, H., Zhang, Y., Xie, F., Sheng, H., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07265-w · Cited by 5
From detection to drug delivery: innovations in cancer biosensors from concept to clinical impact
Singh, S., Rai, S., Bandopadhyay, A., & Das, M. (2025) · Biotechnology for Sustainable Materials · doi:10.1186/s44316-025-00040-3 · Cited by 5
Progress and promise of pharmacodynamic biomarkers: novel strategies and assay considerations in drug development
Fernández‐Metzler, C., Quadrini, K. J., Amaravadi, L. S., Cape, S. S., Green, J., Hays, A. L., Kamphorst, J. J., Laxmanan, S., Pandey, A., Qiu, X. I., et al. (2026) · Bioanalysis · doi:10.1080/17576180.2026.2624362 · Cited by 5
AI in optimized cancer treatment: laying the groundwork for interdisciplinary progress
Kalweit, G., Ullrich, E., Boedecker, J., Mertelsmann, R., & Kalweit, G. (2025) · Oxford Open Immunology · doi:10.1093/oxfimm/iqaf004 · Cited by 4
AI in clinical trials is missing from CONSORT and SPIRIT 2025 guidelines
Ribeiro, H. L., Nepomuceno, F. W. A. B., & Pessoa, C. (2025) · The Lancet · doi:10.1016/s0140-6736(25)01268-1 · Cited by 4
Molecular markers for the efficacy of neoadjuvant immunotherapy for head and neck squamous cell carcinoma
Zhu, J., & Ning, Y. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1586130 · Cited by 4
Brain metastasis in non‐small cell lung cancer: High‐risk factors and predictive models
Chen, G., Zhao, B., Mao, S., Liu, Q., Zhao, Y., Liu, Y., Luo, Y., & Li, Q. (2025) · Open Research (University of Surrey) · doi:10.1002/viw.20250046 · Cited by 3
ZebraMap: A Multimodal Rare Disease Knowledge Map with Automated Data Aggregation & LLM-Enriched Information Extraction Pipeline
Islam, M. S., Jamal, A. T., & Alkhathlan, A. (2025) · Diagnostics · doi:10.3390/diagnostics16010107 · Cited by 3
Pilot study of screening method for pancreatic cancer using lipidomic profiling of plasma or serum
Peterka, O., Jirásko, R., Dolečková, Z., Dosoudilová, M., Bártl, J., Idkowiak, J., Slavíček, O., Pešková, K., Vošmik, M., Mohelníková-Duchoňová, B., et al. (2026) · Communications Medicine · doi:10.1038/s43856-026-01445-5 · Cited by 3
Ensemble learning of pathology foundation models for precision oncology
Luo, X., Wang, X., Eweje, F. R., Zhang, X., Marti, J. L. G., Cascarino, S., Yang, S., Li, Y., Quinton, R. J., Xiang, J., et al. (2026) · Cancer Cell · doi:10.1016/j.ccell.2026.08.008 · Cited by 17
影像组学在非小细胞肺癌免疫治疗中的研究进展
Hou, Y., Zhang, T.-M., & Wang, H. (2024) · Zhongguo fei ai za zhi = Chinese journal of lung cancer · doi:10.3779/j.issn.1009-3419.2024.102.29 · Cited by 2
Novel Computational and Artificial Intelligence Models in Cancer Research
Liu, L., Li, F., Liu, X., Wang, K., & Zhao, Z. (2025) · Cancers · doi:10.3390/cancers17010116 · Cited by 3
The 100 most-cited radiomics articles in cancer research: A bibliometric analysis
Zhang, W., Zhuang, D., Wei, W., Yang, Y., Ma, L., Du, H., Jin, A., He, J., & Li, X. (2025) · Clinical Imaging · doi:10.1016/j.clinimag.2025.110442 · Cited by 3
Advancements and implications of artificial intelligence for early detection, diagnosis and tailored treatment of cancer
Chadha, S., Mukherjee, S., & Sanyal, S. (2025) · Seminars in Oncology · doi:10.1016/j.seminoncol.2025.152349 · Cited by 6
Advances in AI-driven applications of metal-organic frameworks for the diagnosis and treatment of pancreatic cancer
Shi, C.-Y., Chen, G., Ye, M., Xia, Z., Ye, Y., Kushwaha, A., Wang, J., Kumar, A., & Pan, Y. H. (2025) · Dyes and Pigments · doi:10.1016/j.dyepig.2025.112957 · Cited by 4
The impact of artificial intelligence on a multi-omics approach toward predictive biomarkers for non-small cell lung cancer
Wilkins, B., Hartman, E., Kelley, B., Pachika, P. S., Bradley, J., & Bradley, J. A. (2025) · Exploration of Digital Health Technologies · doi:10.37349/edht.2025.101153 · Cited by 3
Identification of biomarkers for endometriosis based on summary-data-based Mendelian randomization and machine learning
Xie, Z., Feng, Y., He, Y., Lin, Y., & Wang, X. (2025) · Medicine · doi:10.1097/md.0000000000041804 · Cited by 3
Artificial intelligence: A transformative tool in precision oncology
McGale, J., Liao, M. J., Lopci, E., Marabelle, A., & Dercle, L. (2024) · Oncotarget · doi:10.18632/oncotarget.28639 · Cited by 3
ImmuneFM: Pre-training Foundation Model from Cytometry Data for Immunology ResearchPreprint
Ding, S., Bhattacharya, S., & Butte, A. J. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.09.664020 · Cited by 3
Proteomic insights into the biology of dopaminergic neurons
Cavarischia-Rega, C., Sharma, K., Fitzgerald, J. C., & Maček, B. (2025) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2025.1642519 · Cited by 3
Artificial Intelligence and Machine Learning Approaches in Designing Immunotherapy in Cancer
Seth, L., Ladbury, C. J., & Amini, A. (2025) · Cancer treatment and research · doi:10.1007/978-3-031-97242-3_2 · Cited by 2
Targeting archetypes of viral-driven cancers with immunotherapy: a perspective on immunogenicity within the tumor microenvironment
Lee, K., Kim, S., Zhao, J., & Neo, S. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1631258 · Cited by 2
Development of a Machine Learning Model Integrating Pathomics and Clinical Data to Predict Axillary Lymph Node Metastasis in Breast Cancer: A Two‐Center Study
Wang, L., Qu, F., Wen, P., Luo, Y., Zhang, H., Li, S., Yin, X., Zhao, Y., & Zeng, X. (2025) · Cancer Reports · doi:10.1002/cnr2.70302 · Cited by 2
Harnessing biomarkers to guide immunotherapy in esophageal cancer: toward precision oncology
Almars, A. I., Shaheen, S. Y., Ghouth, N. M., Abumansour, I. S., Khogeer, A., Alsulaimani, F., Basri, A. M., Elhawary, N. A., Hasan, T., & Almohaimeed, H. M. (2025) · Clinical & Translational Oncology · doi:10.1007/s12094-025-04051-4 · Cited by 3
Clinician Perspectives on Digital and Computational Pathology: Clinical Benefits, Concerns, and Willingness to Adopt
Aggarwal, C., Desai, A. P., McConnell, N., Cadirov, N. A., Gustavsen, G. G., Agarwal, A., Chehab, N. H., Kotapati, S., & Patel, N. R. (2025) · Diagnostics · doi:10.3390/diagnostics15192527 · Cited by 2
Global innovative perspectives and trends on digital health and patient safety: highlights from the #DHPSP2024 networking event
Litvinova, O., Yeung, A. W. K., Echeverría, J., Khader, Y. S., Rahman, M. M., Said, Z., Lach, K., Sidar, B., Koulaouzidis, A., Aremu, A. O., et al. (2025) · Exploration of Digital Health Technologies · doi:10.37349/edht.2025.101166 · Cited by 2
MODAPro: Explainable Heterogeneous Networks with Variational Graph Autoencoder for Mining Disease-Specific Functional Molecules and Pathways from Omics Data
Zhao, J., He, J., Guan, P., Bao, H., Zhao, X., Zhao, C., Qin, W., Lu, X., & Xu, G. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.5c03611 · Cited by 2
Predicability of PD-L1 expression in cancer cells based solely on H&E-stained sections
Faa, G., Fraschini, M., Ziranu, P., Pretta, A., Porcu, G. S., Saba, L., Scartozzi, M., Shokun, N., & Rugge, M. (2025) · Journal of Pathology Informatics · doi:10.1016/j.jpi.2025.100524 · Cited by 3
Beyond conventional images: AI-driven biotechnologies for oral cancer diagnosis – a systematic review
Wang, Y., Chen, C., Gao, Y., Hu, Q., Gao, P., Zheng, Q., Wang, L., Xie, Z., & Chen, X. (2025) · European Journal of Cancer · doi:10.1016/j.ejca.2025.116118 · Cited by 2
AI-Driven Innovations in Translational Research: Accelerating Bench-to-Bedside Pipelines Through Predictive Modelling and Digital Biomarkers
Judijanto, L. (2025) · European Journal of Applied Science Engineering and Technology · doi:10.59324/ejaset.2025.3(6).09 · Cited by 2
Epigenetic Regulation of Autophagy in Breast Cancer: Implications for Biomarker Discovery and Personalized Therapy
Faryal, B. (2025) · Cancer Reports · doi:10.1002/cnr2.70389 · Cited by 2
Integrating artificial intelligence ( AI ) into colorectal cancer reporting
Bräutigam, K., Baker, A., Koelzer, V. H., Kather, J. N., & Graham, T. A. (2026) · The Journal of Pathology · doi:10.1002/path.70029 · Cited by 2
Self-citation
Application of artificial intelligence in head and neck squamous cell carcinoma
Wang, P., Tian, J., Zheng, G., Chen, Y., & Ren, X. (2026) · Annals of Medicine · doi:10.1080/07853890.2026.2620191 · Cited by 4
APOLLO11: a bio-data-driven model for clinical and translational research in lung cancer
Prelaj, A., Provenzano, L., Miskovic, V., Ganzinelli, M., Mazzeo, L., Gemelli, M. T., Silvestri, C., Spagnoletti, A., Romanò, R., Brambilla, M., et al. (2026) · npj Precision Oncology · doi:10.1038/s41698-026-01295-3 · Cited by 2
Self-citation
Inferring tumor immune microenvironment -related risk states from pretreatment H&E pathomics and clinical biomarkers to predict checkpoint inhibitor pneumonitis in advanced NSCLC: a multicenter multimodal study
Yuan, L., Wang, Q., Sun, F., Yang, W., Lei, J., Liu, J., Fan, Y., Shan, Y., Lu, Y., Zhang, Y., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1792179 · Cited by 2
Current Insights and Future Directions of Multiomic and Spatial-Omic Analysis in Non–Small Cell Lung Cancer
Church, M., Marshall, G. B., & Krebs, M. (2026) · JCO Precision Oncology · doi:10.1200/po-25-00684 · Cited by 4
Challenges and Controversies in the Diagnosis and Management of Thymic Epithelial Tumors from the Thymic Tumor Subcommittee of the International Association for the Study of Lung Cancer Rare Tumors Committee
Ardeshir‐Larijani, F., Ashrafian, L., Chiappetta, M., Mansilla, D., Mariani, A. W., Menis, J., Rimner, A., Sharma, A., Szołkowska, M., Upadhya, S., et al. (2026) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2026.103611 · Cited by 2
Artificial intelligence for multiscale mechanobiology
Lee, J.-H., Lee, H., & Kim, H. (2026) · Mechanobiology · doi:10.1177/29780241261441387 · Cited by 2
Artificial intelligence in drug research and development: a review of methods and applications in drug repurposing
Zielińska, A., Fornalik, M., Szczepaniak, M., Gimła, M., Lemanska, A., Cielecka‐Piontek, J., & Souto, E. B. (2026) · Briefings in Bioinformatics · doi:10.1093/bib/bbag203 · Cited by 3
Predictive Biomarkers for Immune Checkpoint Inhibitor Efficacy: Challenges, Innovations, and a Pathway to Precision Medicine in the Era of Cancer Immunotherapy
Lee, M., SoRelle, J. A., Everest‐Dass, A., Gerber, D. E., & von Itzstein, M. S. (2026) · Clinical Chemistry · doi:10.1093/clinchem/hvag062 · Cited by 3
Applications of Artificial Intelligence in Cancer Diagnosis and Treatment
Xie, Y., Wang, Z., Zeng, Z., Xin, T., Yuan, S., Qin, F., & Chen, Z. (2026) · Cancer Medicine · doi:10.1002/cam4.72143 · Cited by 2
Biological sequence analysis: Advances, medical applications, and challenges
Wei, H., Shao, J., & Liu, B. (2024) · Fundamental Research · doi:10.1016/j.fmre.2024.12.007 · Cited by 2
Telemedizin und KI-gestützte Diagnostik im Alltag der Viszeralmedizin
Grade, M., & Uslar, V. (2024) · Die Chirurgie · doi:10.1007/s00104-024-02213-8 · Cited by 2
Recent advances of nuclear medicine for tumor precision medicine
Li, D., Liu, Y., Yang, Z., Li, N., & Zhu, H. (2025) · Precision medicine and engineering. · doi:10.1016/j.preme.2025.100032 · Cited by 2
Artificial Intelligence in Biomarker Discovery and Disease Diagnosis-1
Farooq, M., & Banka, A. A. (2025) · Springer eBooks · doi:10.1007/978-981-96-8176-1_6 · Cited by 2
2.5D Deep Learning and Machine Learning for Discriminative DLBCL and IDC with Radiomics on PET/CT
Liu, F., Chen, W., Zhang, J., Zou, J., Gu, B., Yang, H., Hu, S., Liu, X., & Song, S. (2025) · Bioengineering · doi:10.3390/bioengineering12080873 · Cited by 2
Integrating radiomics and real-world data to predict immune checkpoint inhibitor efficacy in advanced non-small-cell lung cancer
Provenzano, L., Favali, M., Mazzeo, L., Spagnoletti, A., Ruggirello, M., Calareso, G., Greco, F. G., Vigorito, R., Quarta, A., Calimeri, F., et al. (2025) · ESMO Real World Data and Digital Oncology · doi:10.1016/j.esmorw.2025.100182 · Cited by 2
Self-citation
Mining tumor and surrounding tissue information using artificial intelligence to predict responses to EGFR-targeted therapies and immunotherapy in lung cancer: a multicenter attribution analysis
Zhang, X.-P., He, Y., Rao, T., Qiu, X.-T., Lai, Q., Zhang, Y.-C., & Zhang, G. (2025) · La radiologia medica · doi:10.1007/s11547-025-02077-w · Cited by 2
Circulating Exosomal Transfer RNA-Related Fragments as Diagnostic Biomarkers for Non-small Cell Lung Cancer
Meng, L., Ma, Z., Ji, Y., Li, G., Wang, S., & Zhang, Z. (2024) · Current Medicinal Chemistry · doi:10.2174/0109298673314235240813060542 · Cited by 1
Advances in radiomics applications for intrahepatic cholangiocarcinoma: a comprehensive review and future directions
Xu, J.-W., Li, B., & Yu, D. (2024) · Hepatoma Research · doi:10.20517/2394-5079.2024.79 · Cited by 1
Multicenter evaluation of predictive clinical and imaging factors for pathological response in non-small cell lung cancer patients treated with neoadjuvant chemotherapy and immune checkpoint inhibitors
Zhang, M., Meng, Y., Li, Z., Jiang, S., Zuo, L., Zhang, Z., & Zhang, Z. (2025) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-025-04017-z · Cited by 1
Artificial Intelligence and Cancer Immunotherapy
Shah, A., Bhat, A. A., Bhat, M. R., Assad, A., & Macha, M. A. (2025) · Springer eBooks · doi:10.1007/978-981-96-8176-1_16 · Cited by 1
Role of Immunotherapy in Ovarian Cancer: Advances, Challenges, and Future Perspectives
Garg, P., Singhal, G., Pareek, S., Khan, A., Tan, T., Wheeler, D. L., & Singhal, S. S. (2025) · Cancer treatment and research · doi:10.1007/978-3-031-97242-3_10 · Cited by 4
Evaluating the combined efficacy of Telisotuzumab Vedotin and artificial intelligence in the treatment of non-squamous non-small cell lung cancer: a narrative review focusing on pharmaceutical and technical insights
Fatima, S., Faisal, S., Batool, S. V., Faisal, M., Aamir, T., Shahid, Z. U. A., & Mahato, R. K. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1673586 · Cited by 2
Advancing small cell lung cancer metastasis research: innovations in preclinical mouse models
Zhao, Q., Hu, L., & Ji, H. (2025) · Cancer and Metastasis Reviews · doi:10.1007/s10555-025-10301-2 · Cited by 1
Machine Learning and Mendelian Randomization Identify Allergic Rhinitis as Nasopharyngeal Carcinoma Risk Factor With Validated Potential Candidate Biomarkers
Chen, M., Yang, B., Gong, C., Liao, X., & He, K. (2025) · International Journal of Genomics · doi:10.1155/ijog/2281787 · Cited by 1
Real-world data and evidence: pioneering frontiers in precision oncology
Jiang, J., Pan, W., Sun, L. P., Pang, L., Chen, H., Huang, J., & Chen, W. (2025) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2400285 · Cited by 1
Tumour markers and evidence-based pathology
Maslova, K. I., Chechlińska, M., Michałek, I. M., Taraszkiewicz, Ł., Kober, P., Trulson, I., Worf, K., Gabriel, S., Knoblauch, L., Campbell, F., et al. (2026) · Tumor Biology · doi:10.1177/14230380251410478 · Cited by 1
Integrative Genomic and AI Approaches to Lung Cancer and Implications for Disease Prevention in Former Smokers
Benard, K., Souza, V. G. P., Stewart, G. L., Enfield, K. S. S., & Lam, W. L. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27010521 · Cited by 1
Risk Factors and Prediction Model for Early‐Onset Immune‐Related Adverse Events in Pan‐Cancer Patients Undergoing Anti‐ PD ‐(L)1 Therapy: A Retrospective Study in a Tertiary‐Level Hospital
Jiao, P., Xue, L., Tan, W., Chen, Q. Q., Lin, S. Q., Song, M. S., Ma, C., & Zhan, J. (2026) · Cancer Medicine · doi:10.1002/cam4.71603 · Cited by 1
A machine learning-based predictive model for radiosensitivity in nasopharyngeal carcinoma utilizing serum proteomics
Lei, M., Xu, L., Wei, P., Liangfangshen, & Li, Z. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-07847-2 · Cited by 1
A machine learning model integrating circulating Temra cell transcriptional profiles to predict immunotherapy efficacy.
Dong, Y.-C., Xu, X., Si, H.-J., Li, Y., Yang, D.-L., Chen, J.-Y., Wang, Y.-Z., Zhang, H.-M., Yang, L., Xie, H.-K., et al. (2026) · i Medicina · doi:10.1016/j.medj.2026.101027 · Cited by 1
Biomarker-guided immunotherapy in gastric cancer: current insights and future perspectives
Mulet, M. T., Rodríguez, J. V., Terán, E., Piñol, M., Vilardell, F., Iglesias, M., Hierro, C., Calvo, M., Matías‐Guiu, X., Salud, A., et al. (2026) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2026.103124 · Cited by 1
Cancer in transition: discovery of tumor-intrinsic transcriptional programs shaping the immune and microenvironmental landscape
Spitschak, A., Casalegno‐Garduño, R., & Pützer, B. M. (2026) · Biomarker Research · doi:10.1186/s40364-026-00925-z · Cited by 2

Authors: Prelaj, A., Miskovic, V., Zanitti, M., Trovo, F., Genova, C., Viscardi, G., Rebuzzi, S. E., Mazzeo, L., Provenzano, L., Kosta, S., Favali, M., Spagnoletti, A., Castelo-Branco, L., Dolezal, J., Pearson, A. T., Lo Russo, G., Proto, C., Ganzinelli, M., Giani, C., Ambrosini, E., Turajlic, S., Au, L., Koopman, M., Delaloge, S., Kather, J. N., de Braud, F., Garassino, M. C., Pentheroudakis, G., Spencer, C., & Pedrocchi, A. L. G.
Affiliations: European Society for Medical Oncology (CH)
Fondazione Politecnico di Milano (IT)
Aalborg University (DK)
Ospedale Policlinico San Martino (IT)
University of Campania "Luigi Vanvitelli" (IT)
Ospedale San Paolo (IT)
Fondazione IRCCS Istituto Nazionale dei Tumori (IT)
Politecnico di Milano (IT)
University of Chicago (US)
The Francis Crick Institute (GB)
Royal Marsden NHS Foundation Trust (GB)
Else Kröner Fresenius Center for Digital Health (DE)
Corresponding author: Prelaj, A.
ORCID: Prelaj, A.
Miskovic, V.
Genova, C.
Viscardi, G.
Rebuzzi, S.E.
Mazzeo, L.
Provenzano, L.
Kosta, S.
Spagnoletti, A.
Dolezal, J.
Pearson, A.T.
Proto, C.
Ganzinelli, M.
Ambrosini, E.
Turajlic, S.
Au, L.
Koopman, M.
Delaloge, S.
Kather, J.N.
Garassino, M.C.
Pentheroudakis, G.
Pedrocchi, A.L.G.
Venue: Annals of Oncology
Publisher: Elsevier BV
Published: 2024-01
Volume: 35
Issue: 1
Pages: 29-65
ISSN: 0923-7534 (ISSN-L)
DOI: 10.1016/j.annonc.2023.10.125
OpenAlex: W4387881611
Cited by: 340
References: 150
Citations by year: 2026: 131 · 2025: 149 · 2024: 60
FWCI: 11.08
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 366 d)
Locations: Annals of Oncology (publishedVersion)
PubMed (publishedVersion)
VBN Forskningsportal (Aalborg Universitet) (acceptedVersion, other-oa)
Virtual Community of Pathological Anatomy (University of Castilla La Mancha) (submittedVersion, other-oa)
CINECA IRIS Institutial Research Information System (University of Genoa) (submittedVersion)
VBN Forskningsportal (Aalborg Universitet) (submittedVersion)
Funders: Gilead Sciences
AbbVie
Cancer Research Foundation
Topics: Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiomics and Machine Learning in Medical Imaging
Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
Keywords: artificial intelligence, predictive biomarkers, immune checkpoint inhibitors, cancer immunotherapy, immunotherapy response prediction, radiomics, digital pathology, pathomics, genomics, transcriptomics, epigenomics, multimodal data integration, non-small cell lung cancer, melanoma, precision oncology
MeSH terms: Artificial Intelligence, Carcinoma, Non-Small-Cell Lung, Humans, Lung Neoplasms, Medical Oncology, Prospective Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Artificial intelligence for predictive biomarker discovery in immuno-oncology: a systematic review

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks